Miyako Murakawa

Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C

Hiroko Nagata, Mina Nakagawa, Yasuhiro Asahina et al. · Journal of Hepatology · 2017 · 209 citations

Medicine, Oncology, Hepatology +9

Hepatitis C virus NS4B protein targets STING and abrogates RIG-I–mediated type I interferon-dependent innate immunity

Sayuri Nitta, Naoya Sakamoto, Mina Nakagawa et al. · Hepatology · 2012 · 147 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features

Fukiko Kawai‐Kitahata, Yasuhiro Asahina, Shinji Tanaka et al. · Journal of Gastroenterology · 2015 · 122 citations

Medicine, Molecular Genetics, Oncology +17

Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy

Hiroko Nagata, Mina Nakagawa, Yuki Nishimura‐Sakurai et al. · Hepatology International · 2016 · 62 citations

Medicine, Pathology, Hepatology +14

The early neutrophil-committed progenitors aberrantly differentiate into immunoregulatory monocytes during emergency myelopoiesis

Naoki Ikeda, Hiroaki Kubota, Risa Suzuki et al. · Cell Reports · 2023 · 52 citations · Full text

Life Sciences, Cell Biology, Immunology +12